DUBLIN–(BUSINESS WIRE)–The “Flexible Manufacturing Systems for Pharmaceutical Industry Market By Product Type, By Technology, By End User Industry: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.
The global flexible manufacturing systems for pharmaceutical industry size was valued at $1,962.2 million in 2021 and is projected to reach $3,319.7 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.
A flexible manufacturing system for pharmaceuticals is a system that includes specialized machineries, processes, and operations involved in pharmaceutical manufacturing that are capable of being modified and changed within a short span of time to cope with sudden market changes.
Government and private agencies across the world keep a close eye on the pharmaceutical industry owing to its inherent nature of being associated with the lives of people and animals. Moreover, it is one of the few industries that is highly affected by politics across the world. Along with this, diseases evolve and often develop immunity to medicines. Such factors drive the demand for flexible manufacturing systems for pharmaceutical industry, as they allow quick response to market changes.
Increase in number of patients suffering from diseases such as heart diseases, diabetes, and arthritis rare diseases has significantly increased owing to rise in geriatric population. Furthermore, rise in number of patients has increased the demand for in pharmaceutical industry. These factors positively influence the growth of the flexible manufacturing systems for pharmaceutical industry.
However, requirement for highly skilled professionals for operating and developing flexible manufacturing systems for pharmaceutical is a major restraint in the industry. Furthermore, rise in pharmaceutical industry in the emerging nations provides lucrative growth opportunities for the industry.
Key Benefits
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flexible manufacturing systems for pharmaceutical industry market analysis from 2021 to 2031 to identify the prevailing flexible manufacturing systems for pharmaceutical industry market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the flexible manufacturing systems for pharmaceutical industry market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global flexible manufacturing systems for pharmaceutical industry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Modular manufacturing
- Data-driven manufacturing
- Single-use manufacturing
- Continuous manufacturing
By Technology
- Hardware
- Software
By End User Industry
- Large Pharmaceutical Manufacturers
- Method
- Machine Flexibility
- Volume Flexibility
- Medium and Small Pharmaceutical Manufacturers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Vietnam
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- UAE
- South Africa
- Kenya
Key Market Players
- Angstrom Technology
- Biologics Modular, LLC
- Chempharm
- Cytiva
- ESC (Environmental Systems Corporation)
- Exyte GmbH
- G-CON Manufacturing
- Germfree Laboratories Inc.
- IPM Technologies
- KeyPlants Ab
- ModuleCo Ltd.
- Modwave LLC
- Nicomac Srl
- NNE
- Pharmadule Morimatsu AB
- PR Pharma Engineers Pvt. Ltd.
- Univercells Technologies
For more information about this report visit https://www.researchandmarkets.com/r/u56jfd
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900